PATENT CLAIM ANALYSIS

Application Number: 16291401
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "394000"]

Abstract:
Methods of treatment using bendamustine formulations designed for small volume intravenous administration are disclosed. The methods conveniently allow shorter administration time without the active ingredient coming out of solution as compared to presently available formulations.

Claim (Index 1):
A method of treating cancer or malignant disease in a subject, comprising parenterally administering to a subject in need thereof, a volume of about 100 ml or less of a liquid composition comprising:\n from about 0.05 to about 6 mg/ml of bendamustine or a pharmaceutically acceptable salt thereof; a parenterally acceptable diluent; and optionally an antioxidant; over a substantially continuous period of less than or equal to about 30 minutes.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 99.0
- Lexical Diversity: 1.12121
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14714578', '15184464', '15184488', '13838090', '15008819']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7736835314350654
- 35 USC 102 Novelty (BERT): 0.557799249744775
- Combined Prediction Score: 0.7520951032660363
- Mean Citation Score: 411.256314
- Max Citation Score: 416.11646
- Similarity Product: 338.1980500656772

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test